Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Dynamk Capital
Sort By
Newest First
1 / 1
1 / 1
Real-World Data
How Is Your Organization Currently Leveraging Real-World Data/Evidence and What Uses Do You Anticipate in the Future?
Pharma's Almanac
PAO-09-23-RT-01
September 15, 2023
Industry Wisdom
What Piece of Conventional Industry Wisdom Do You Think is Misguided, Outdated, or Just Plain Wrong?
Pharma's Almanac
PAO-09-23-RT-02
September 15, 2023
Roundtable: Artificial Intelligence
In what areas of pharma/biopharma are you most excited to see increased adoption of artificial intelligence (AI) and machine learning?
Pharma's Almanac
PAO-07-23-RT-01
July 21, 2023
Combining RNA Splicing and AI Technologies to Accelerate Drug Discovery and Development
Martin Akerman, Ph.D.
Envisagenics
PAO-02-23-CL-08
April 12, 2023
Life Science Industrials
Life Science Industrials Are Key to the Growth of the Biopharma Industry
Reinhard Vogt
Dynamk Capital
PAO-07-022-CL-05
August 04, 2022
mRNA Manufacturing
Vernal Biosciences Raises $21 Million to Accelerate mRNA Manufacturing Growth
Vernal Biosciences
PR-M06-22-01-351
June 02, 2022
Seed Funding
Bionter AG secures $3 Million in Series Seed Financing Led by Dynamk Capital
Bionter AG
PR-M04-22-13
April 27, 2022
Cell and Gene Therapy Technology
Advancing Technologies in Cell and Gene Therapy
Gustavo Mahler, Ph.D.
Dynamk Capital
PAO-04-22-R250-09
April 05, 2022
Life Science Industrials
The Potential of Life Science Industrials
Daniella Kranjac
Dynamk Capital
PAO-01-22-R250-05
January 26, 2022
Life Science Industrials
Filling Industry Gaps and Driving Innovation with Life Science Industrials
Reinhard Vogt; Sebastien Latapie
Dynamk Capital
PAO-11-21-CL-01
November 03, 2021
Stem Cells
Curi Bio Raises $6M Series A Financing Round for iPSC-derived Predictive Platforms
Curi Bio
PR-M03-21-004-1062
March 18, 2021
The Future of Healthcare
How Does Dynamk Capital Envision the Future of the Pharma/Biopharma Industry?
Dynamk Capital
PAP-Q4-20-RT2-013
December 09, 2020
Financing
Lucid Scientific Secures $3 Million in Series Seed Financing Led by Dynamk Capital
Lucid Scientific
PR-M10-20-03
October 03, 2020
Organ-on-a-Chip
Organ-on-a-Chip Technology Aims to Disrupt Traditional Drug Testing Models
Gustavo Mahler, Ph.D.; Jessica Davis
Dynamk Capital
PAP-Q3-20-CL-014
September 29, 2020
The Future of Healthcare
How Is Dynamk Capital Facing the Future of Healthcare?
Dynamk Capital
PAP-Q3-20-RT2-013
September 29, 2020
Leadership
Dr. Gustavo Mahler Now a General Partner at Dynamk Capital
Dynamk Capital
PR-M04-20-NI-013-1618
April 07, 2020
Strategic Partnership
Facilitating the Commercialization of Disruptive Industrial Life Science Technologies
Gustavo Mahler, Ph.D.; Daniella Kranjac
Dynamk Capital
PAP-Q1-20-CL-031
March 19, 2020
